MORINO, STEFANIA
 Distribuzione geografica
Continente #
NA - Nord America 1.044
EU - Europa 422
AS - Asia 147
AF - Africa 24
SA - Sud America 9
Totale 1.646
Nazione #
US - Stati Uniti d'America 1.033
IT - Italia 271
IN - India 71
SE - Svezia 26
CN - Cina 25
TG - Togo 17
DE - Germania 15
GB - Regno Unito 14
JP - Giappone 14
FR - Francia 12
BG - Bulgaria 11
FI - Finlandia 9
IE - Irlanda 9
HK - Hong Kong 8
VN - Vietnam 8
AT - Austria 7
CA - Canada 7
ES - Italia 7
AL - Albania 5
RS - Serbia 5
UA - Ucraina 5
CH - Svizzera 4
NL - Olanda 4
PH - Filippine 4
TR - Turchia 4
AR - Argentina 3
BR - Brasile 3
CZ - Repubblica Ceca 3
MK - Macedonia 3
RO - Romania 3
SC - Seychelles 3
AE - Emirati Arabi Uniti 2
CO - Colombia 2
CR - Costa Rica 2
IS - Islanda 2
MA - Marocco 2
MX - Messico 2
PK - Pakistan 2
SG - Singapore 2
TH - Thailandia 2
TW - Taiwan 2
UG - Uganda 2
BE - Belgio 1
BY - Bielorussia 1
CL - Cile 1
EE - Estonia 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
ID - Indonesia 1
PL - Polonia 1
SA - Arabia Saudita 1
UZ - Uzbekistan 1
Totale 1.646
Città #
Fairfield 146
Chandler 121
Ashburn 91
Rome 83
Woodbridge 71
Seattle 66
Cambridge 60
Houston 60
Wilmington 56
Milan 36
Princeton 28
San Paolo di Civitate 27
New York 24
Lawrence 23
Dearborn 20
Lomé 17
Ann Arbor 16
San Diego 16
Beijing 11
Boston 11
Millbury 11
Sofia 11
Bengaluru 9
Dublin 9
Helsinki 9
Hong Kong 8
Plano 7
Ponzano Veneto 7
Fasano 6
Fremont 6
Bremen 5
Chicago 5
Des Moines 5
Hanoi 5
Naples 5
San Mateo 5
Tokyo 5
Vienna 5
Andover 4
Boardman 4
Frankfurt am Main 4
Istanbul 4
Nanjing 4
Norwalk 4
Oxford 4
Paris 4
Sordio 4
Bari 3
Cascina 3
Dallas 3
Kyoto 3
Manchester 3
Portland 3
Toronto 3
Zurich 3
Bangkok 2
Barcelona 2
Bien Hoa 2
Bouc-Bel-Air 2
Buffalo 2
Cincinnati 2
Dubai 2
Genoa 2
Heiseicho 2
Innsbruck 2
Keflavik 2
La Spezia 2
Madrid 2
Mahé 2
Melzo 2
Mexico City 2
New Taipei 2
Nis 2
Oulad Teima 2
Pardubice 2
Prescot 2
Reggio Emilia 2
Romainville 2
Saint-Augustin-de-Desmaures 2
Saint-Fons 2
San Juan 2
Santa Coloma de Gramenet 2
Sapporo 2
Stara Pazova 2
Struga 2
Tirana 2
Torre Del Greco 2
Verona 2
Vitória da Conquista 2
Zelaya 2
Amsterdam 1
Annapolis 1
Aprilia 1
Atlanta 1
Belgrade 1
Binangonan 1
Bogotá 1
Boisar 1
Boulder 1
Brasília 1
Totale 1.246
Nome #
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN). a phase 3, randomised, double-blind, placebo-controlled, multicentre study 129
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT). a multicentre, randomised, placebo-controlled, phase 3 trial 123
Eculizumab improves fatigue in refractory generalized myasthenia gravis 113
Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension 95
Nerve high-resolution ultrasonography in peripheral nerve injuries associated with supracondylar humeral fractures in children 85
A 34-year longitudinal study on long-term cardiac outcomes in DM1 patients with normal ECG at baseline at an Italian clinical centre 80
Widening the phenotypical spectrum of EGR2-related CMT: unusual phenotype for R409W mutation 80
Multifocal motor neuropathy following treatment with adalimumab for ulcerative colitis 74
Intravenous versus subcutaneous immunoglobulin – authors' reply 73
Long-term safety and efficacy of eculizumab in generalized myasthenia gravis 69
Changes of clinical, neurophysiological and nerve ultrasound characteristics in CIDP over time: a 3-year follow-up 66
Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis. 2-year extension of the MGTX randomised trial 62
Muscle involvement in myasthenia gravis: Expanding the clinical spectrum of Myasthenia-Myositis association from a large cohort of patients 62
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH). a randomised, double-blind, placebo-controlled, phase 3 trial 57
Consistent improvement with eculizumab across muscle groups in myasthenia gravis 52
Gender effect on cardiac involvement in myotonic dystrophy type 1 52
Skin biopsy and quantitative sensory assessment in an Italian cohort of ATTRv patients with polyneuropathy and asymptomatic carriers: possible evidence of early non-length dependent denervation 50
Efficacy and safety of IVIG in CIDP. Combined data of the PRIMA and PATH studies 49
Novel ACTA1 mutation causes late-presenting nemaline myopathy with unusual dark cores 48
Plasma-exchange responsive delayed pseudochoreoathetosis in a patient with anti-Hu neuronopathy 42
Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): Refining muscle involvement and implications for clinical trials 41
Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy. Results from the pre-randomization phase of the Polyneuropathy And Treatment with Hizentra study 39
Quantitative sensory testing and skin biopsy findings in late‐onset ATTRv pre‐symptomatic carriers: relationships with predicted time of disease onset (PADO) 37
Nerve ultrasonography findings as possible pitfall in differential diagnosis between hereditary transthyretin amyloidosis with polyneuropathy and chronic inflammatory demyelinating polyneuropathy 36
Muscle MRI in immune-mediated necrotizing myopathy (IMNM). implications for clinical management and treatment strategies 33
High-resolution ultrasound of peripheral nerves in late-onset hereditary transthyretin amyloidosis with polyneuropathy: similarities and differences with CIDP 32
Distal upper limb involvement in myasthenia-myositis association 27
Comparison of quantitative muscle ultrasound and whole-body muscle MRI in facioscapulohumeral muscular dystrophy type 1 patients 24
Prominent mitochondrial pathology in a case of refractory dermatomyositis: coincidence or concause? 17
Nerve high-resolution ultrasound in a 2-years follow-up of radial nerve palsy related to humeral shaft fractures 12
Eculizumab for myasthenic exacerbation during treatment with immune-checkpoint inhibitors 10
Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis (Quality of Life Research, (2019), 28, 8, (2247-2254), 10.1007/s11136-019-02148-2) 10
Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis. A subgroup analysis of the REGAIN open-label extension study 6
null 4
Totale 1.789
Categoria #
all - tutte 5.126
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.126


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201967 0 0 0 0 0 0 0 0 0 14 28 25
2019/2020289 15 3 1 9 23 38 59 47 42 21 18 13
2020/2021228 13 11 41 12 11 9 14 11 28 44 20 14
2021/2022352 43 11 32 18 48 25 16 26 15 15 65 38
2022/2023479 49 85 13 63 45 55 29 30 39 14 38 19
2023/2024325 11 36 19 37 31 63 22 50 12 44 0 0
Totale 1.789